AstraZeneca

    • EU, AstraZeneca end litigation, reach agreement on vaccine supply

      EU, AstraZeneca end litigation, reach agreement on vaccine supply

      The EU and AstraZeneca reached on Friday an agreement which will secure the delivery of the remaining Covid-19 vaccine doses to Member States under the terms of the Advance Purchase Agreement concluded on 27 August 2020 with AstraZeneca, EC Press service reported. The agreement will also end the pending litigation before the Brussels Court."Today's settlement agreement guarantees the delivery of the remaining 200 million Covid-19 vaccine doses by AstraZeneca to the EU,” Commissioner for Health and Food Safety Stella Kyriakides said.

      78
    • AstraZeneca's antibody therapy blocks Covid-19

      AstraZeneca's antibody therapy blocks Covid-19

      The pharmaceutical conglomerate AstraZeneca announced that its antibody therapy met the main goal of preventing Covid-19 disease in a late-stage study, Reuters reported. The announcement is putting the British company in position to offer an alternative cure to vaccines for people with weakened immune systems.

      65
    • Italy halts AstraZeneca vaccine for under 60s

      Italy halts AstraZeneca vaccine for under 60s

      The Italian government announced it was once again restricting the use of the AstraZeneca Covid-19 vaccine to people over the age of 60, after it caused the death of a teenager. As EUROPOST reminds, Camilla Canepa died on Thursday aged 18 after being given the vaccine on 25 May, triggering a media and political outcry over the Anglo-Swedish company's shot being used for adults of all ages despite previously-raised medical concerns.

      436
    • EU rules on AstraZeneca-Alexion $39bn merger

      EU rules on AstraZeneca-Alexion $39bn merger

      EU antitrust regulators are expected to rule by the beginning of July if they allow a merger between the pharmaceutical conglomerates AstraZeneca and the US Alexion, Reuters reported. The value of the expected deal is estimated at some 39 billion dollars. AstraZeneca is a producer of one of the approved vaccines against Covid-19.

      164
    • EU and AstraZeneca battle in court

      EU and AstraZeneca battle in court

      The Commission will confront today AstraZeneca in a Belgian court over coronavirus vaccine delivery shortfalls that hampered efforts to kickstart inoculations across the bloc, news wires reported. Lawyers for both sides were due to appear before a judge in the French-speaking court in Brussels already in the morning. Another hearing is scheduled for Friday.

      113
    • Norway removes AstraZeneca from vaccination campaign

      Norway removes AstraZeneca from vaccination campaign

      Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, PM Erna Solberg announced on Wednesday, dpa reported. She said the decision was based on the advice of a committee of experts and the Norwegian Institute of Public Health (FHI), which recommended excluding the shots made by AstraZeneca and Johnson & Johnson due to the risk of very rare but serious side effects.

      110
    • Slovakia halts use of AstraZeneca vaccine as a woman dies

      Slovakia halts use of AstraZeneca vaccine as a woman dies

      Slovakia's Health Ministry announced on Tuesday it was suspending the use of AstraZeneca's COVID-19 vaccine for people getting their first doses, after experts reviewed the death of a recipient, Reuters reported. The state drug regulator, SUKL, said last week that the death of a 47-year-old woman was likely to be connected to the vaccine because of a predisposition that she had.

      146
    • EU puts off new contract with AstraZeneca

      EU puts off new contract with AstraZeneca

      EU has not yet made any orders for additional Covid-19 jabs from AstraZeneca and talks related to a new contract have stalled, Reuters reported. Internal Market Commissioner Thierry Breton confirmed that at this stage no additional vaccines from this producer are expected beyond June when the current contract expires. Breton also noted that EU will pay higher price for the new version of the Pfizer-BioNTech vaccine.

      148